These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 18777612

  • 1. Aliskiren combined with losartan in diabetes and nephropathy.
    Lindner T.
    N Engl J Med; 2008 Sep 04; 359(10):1068-9; author reply 1069-70. PubMed ID: 18777612
    [No Abstract] [Full Text] [Related]

  • 2. Aliskiren combined with losartan in diabetes and nephropathy.
    Anderson S, Komers R.
    N Engl J Med; 2008 Sep 04; 359(10):1069; author reply 1069-70. PubMed ID: 18777613
    [No Abstract] [Full Text] [Related]

  • 3. Aliskiren and dual therapy in type 2 diabetes mellitus.
    Ingelfinger JR.
    N Engl J Med; 2008 Jun 05; 358(23):2503-5. PubMed ID: 18525047
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension.
    Doulton TW, MacGregor GA.
    J Renin Angiotensin Aldosterone Syst; 2009 Dec 05; 10(4):185-9. PubMed ID: 19617273
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aliskiren combined with losartan in diabetes and nephropathy.
    Kamoi K.
    N Engl J Med; 2008 Sep 04; 359(10):1069; author reply 1069-70. PubMed ID: 18777611
    [No Abstract] [Full Text] [Related]

  • 9. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T.
    Hypertens Res; 2008 Jan 04; 31(1):59-67. PubMed ID: 18360019
    [Abstract] [Full Text] [Related]

  • 10. Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients?
    Gaddam KK, Oparil S.
    Curr Opin Nephrol Hypertens; 2008 Sep 04; 17(5):484-90. PubMed ID: 18695389
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aliskiren/valsartan (Valturna) for hypertension.
    Med Lett Drugs Ther; 2009 Nov 30; 51(1326):94-5. PubMed ID: 20224524
    [No Abstract] [Full Text] [Related]

  • 14. Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients.
    López V, Martin M, Cobelo C, Aranda P, Cabello M, Sola E, Gutierrez C, Burgos D, Martínez D, Hernandez D.
    Transplant Proc; 2010 Oct 30; 42(8):2883-5. PubMed ID: 20970559
    [Abstract] [Full Text] [Related]

  • 15. Renin inhibition with aliskiren.
    Wuerzner G, Azizi M.
    Clin Exp Pharmacol Physiol; 2008 Apr 30; 35(4):426-30. PubMed ID: 18307734
    [Abstract] [Full Text] [Related]

  • 16. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.
    Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA.
    Nephrol Dial Transplant; 2009 May 30; 24(5):1663-71. PubMed ID: 19145003
    [Abstract] [Full Text] [Related]

  • 17. Renin inhibition in hypertension.
    Gradman AH, Kad R.
    J Am Coll Cardiol; 2008 Feb 05; 51(5):519-28. PubMed ID: 18237679
    [Abstract] [Full Text] [Related]

  • 18. Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker.
    Chrysostomou A, Pedagogos E, MacGregor L, Becker GJ.
    Clin J Am Soc Nephrol; 2006 Mar 05; 1(2):256-62. PubMed ID: 17699214
    [Abstract] [Full Text] [Related]

  • 19. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S.
    Acta Med Indones; 2008 Jan 05; 40(1):34-7. PubMed ID: 19054878
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.